Systemic Markers of Inflammation in Neuroendocrine Tumors (NETs) and Outcomes with Everolimus: A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials - Chan, D. L.; Yao, J. C.; Carnaghi, C.; Buzzoni, R.; Herbst, F.; Ridolfi, A.; Strosberg, J.; Kulke, M.; Pavel, Marianne Ellen; Singh, S. (2018)
EVALuna2:34116